June 20, 2014 — The chemotherapy drug docetaxel, marketed as Taxotere by Sanofi-Aventis, contains ethanol that can cause alcohol intoxication, according to a Drug Safety Communication from the U.S. Food and Drug Administration (FDA).
The FDA is altering labels on the drug, which is administered intravenously and used to treat cancers of the breast, prostate, stomach, head and neck, and non-small cell lung cancer.
There are at least eight formulations of docetaxel, including generic and brand-name products, from several manufacturers. The alcohol content in each 200-mg dose ranges from a low of 2 grams in Taxotere to a high of 6.4 grams in docetaxel injections manufactured by Pfizer.
The FDA has received three reports of patients who experienced alcohol intoxication after being treated with docetaxel. Two incidents occurred during the infusion; one patient developed symptoms within 24 hours.
According to the FDA:
“Patients should be aware that docetaxel may cause them to become intoxicated from the alcohol it contains. Patients should avoid driving, operating machinery, or performing other activities that are dangerous for one to two hours after the infusion of docetaxel.”
Healthcare professionals can minimize the risk of injuring a patient by carefully considering the dose of ethanol in each infusion — especially patients who are on other medications that intensify the intoxicating effects of alcohol, such as sleep aids and pain relievers.
Do I have a Docetaxel Lawsuit?
The Schmidt Firm, PLLC is currently accepting docetaxel induced injury cases in all 50 states. If you or somebody you know has been injured by ethanol or alcohol intoxication, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.